The Swiss company, which markets Elevidys abroad, said it believes the benefit-risk balance to treatment remains positive in Duchenne patients who can still walk, however.

The abstracts accepted for mini oral presentations include updated efficacy and safety data from the Phase 2b REZILIENT1 ...

Aquestive Therapeutics, Inc. (NASDAQ: AQST) ('Aquestive” or the 'Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...

Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement ...

United Therapeutics Corporation (NASDAQ:UTHR) is among the most undervalued stocks to invest in. It is a biotechnology ...

United Therapeutics (UTHR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports ...

Roche Holding AG said on Tuesday it has paused all shipments of muscular disorder gene therapy Elevidys outside the U.S., ...

Against that backdrop, United Therapeutics is facing specific questions about near-term sales performance, particularly ...

Tulavi Therapeutics, a private medical technology company focused on advancing surgical solutions that address critical unmet ...

A high-level overview of United Therapeutics Corporation (UTHR) stock. View (UTHR) real-time stock price, chart, news, analysis, analyst reviews and more.

The United States has rejected amendments adopted in 2024 by members of the World Health Organization to its legally binding ...